We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Improvement of Accommodation With Anti-Oxidant Supplementation in Visual Display Terminal Users

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00877201
Recruitment Status : Completed
First Posted : April 7, 2009
Last Update Posted : April 8, 2009
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to determine the antioxidant supplementation effect on accommodation among visual display terminal (VDT) users.

Condition or disease Intervention/treatment
Ocular Accommodation Drug: CDR2

Study Design

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Supportive Care
Study Start Date : March 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Antioxidants
U.S. FDA Resources

Arms and Interventions


Outcome Measures

Primary Outcome Measures :
  1. accommodation changes

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 49 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • best corrected visual acuity is over 20/20

Exclusion Criteria:

  • receiving any medication or supplement that would alter the accommodation status within a week from the commencement of this study
  • using multifocal spectacles or contact lenses
  • pregnant or lactating mothers
  • subjects with a history of drug allergy
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00877201


Locations
Japan
Iidabashi Eye Clinic
Tokyo, Japan, 102-0072
Sponsors and Collaborators
Ryogoku Eye Clinic
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00877201     History of Changes
Other Study ID Numbers: Ryogoku6886
First Posted: April 7, 2009    Key Record Dates
Last Update Posted: April 8, 2009
Last Verified: April 2009

Keywords provided by Ryogoku Eye Clinic:
Accommodation
visual display terminal (VDT)
antioxidant